Arne Faisst holds more than two decades of experience in leading management positions in the Medtech industry. He has worked for national and international companies and has detailed knowledge of the diagnostic market. He understands himself as a motivator. As a PhD biochemist and holder of an executive MBA at State University at Albany, New York, he is an expert both in the fields of molecular cell biology as well as in marketing and finance.

Julia Godau completed her PhD in Natural Sciences at the Institute of Molecular Cancer Research of the University of Zurich. With more than 10y+ experience in molecular cancer research in Academia and companies like Roche she is Chief Scientific Officer at 4D Lifetec AG in diagnostic assay development.

Dr. Frank Städtler is a well know genomics and genetics biomarker expert. He worked over 25 years as a pharma R&D professional and biomarker scientist and holds a deep expertise in diagnostically, pre-clinical and clinically applied nucleic acid analytical technologies. He worked for Novartis Pharma Development as well as the Novartis Institutes for BioMedical Research and the Roche Pharma AG in different leading positions as senior scientist.

Oliver Schicht holds 15y+ experience in the development of diagnostic instrumets and disposables. He also is a specialist in applied system engineering.

Andreas Thomsen is Chief Oncologist at the University of Freiburg, Germany